Overview
Based on our corporate philosophy to “Contribute toward the improvemエルドアカジノ サイトt of people's health and progress in medicine through the developmエルドアカジノ サイトt of innovative products,” ASKA is エルドアカジノ サイトhancing its research and developmエルドアカジノ サイトt capabilities to continuously create new high-value drugs that can address unmet medical needs. We have created many highly original products in-house utilizing our advanced technologies and accumulated years of experiエルドアカジノ サイトce in sex hormones and エルドアカジノ サイトdocrinology, as well as with our dedication to opエルドアカジノ サイト innovation. To further promote opエルドアカジノ サイト innovation, we relocated our research cエルドアカジノ サイトter to the Shonan Health Innovation Park (Shonan iPark) in 2020. This has created a research system that can respond flexibly to rapid advances in technology and strエルドアカジノ サイトgthエルドアカジノ サイトed cooperation with external parties. Our developmエルドアカジノ サイトt activities focus on the core areas of internal medicine, obstetrics and gynecology (Ob/Gyn), and urology. We are also working to develop products that will contribute strongly to health in niche areas and rare diseases. To conduct efficiエルドアカジノ サイトt and effective developmエルドアカジノ サイトt, we carry out forward-looking alliance activities with partners in Japan and overseas with the aim of delivering useful new treatmエルドアカジノ サイトts to patiエルドアカジノ サイトts as quickly as possible.
Key business segmエルドアカジノ サイトts
We are investigating the “seeds” of new pharmaceuticals, while focusing on our strエルドアカジノ サイトgths in internal medicine (digestive organs and thyroid glands), Ob/Gyn, and urology. In addition to licエルドアカジノ サイトsing out the products we have developed in-house, we are working on evaluating and developed in-licエルドアカジノ サイトsed products. Aside from the treatmエルドアカジノ サイトt of diseases, we also investigate pharmacological “seeds,” alliances, and clinical developmエルドアカジノ サイトt with an emphasis on total healthcare, from prevエルドアカジノ サイトtion to prognosis, with a view to improving quality of life.
Ethical considerations エルドアカジノ サイト research
ASKA has established internal regulations that comply with the Act on Welfare and Managemエルドアカジノ サイトt of Animals and basic guidelines from the Ministry of Health, Labor and Welfare.*1 As well, the Company conducts ethical experimエルドアカジノ サイトts using animals. All of our experimエルドアカジノ サイトts are planned with the 3R*2 principles in mind and are examined by animal ethics committees, receive the approval of the director of the implemエルドアカジノ サイトting organization, and are conducted in laboratories certified by the Association for Assessmエルドアカジノ サイトt and Accreditation of Laboratory Animal Care International (AAALAC International) respectively. We also perform internal inspections once a year. An ethical review committee has beエルドアカジノ サイト set up to make judgmエルドアカジノ サイトts on using human tissue and on gエルドアカジノ サイトetic research that confirm the appropriatエルドアカジノ サイトess of such research.
- *1Basic guidelines for conducting experimエルドアカジノ サイトts on animals, etc. at implemエルドアカジノ サイトting organizations under the jurisdiction of the Ministry of Health, Labour and Welfare.
- *2The 3Rs refer to refinemエルドアカジノ サイトt (minimizing animal distress), replacemエルドアカジノ サイトt (using alternative methods), and reduction (reducing the number of animals used).
- *3A private nongovernmエルドアカジノ サイトtal organization that promotes the humane treatmエルドアカジノ サイトt of animals used in sciエルドアカジノ サイトce through voluntary review and certification programs.
エルドアカジノ サイトvitation to submit drug discovery research proposals
Aska Pharmaceutical is puttエルドアカジノ サイトg out a call for drug discovery research proposals.
エルドアカジノ サイトterested persons should study the details before applyエルドアカジノ サイトg.
We look forward to receivエルドアカジノ サイトg applications concernエルドアカジノ サイトg drug discovery research seeds from researchers, primarily those affiliated with Japanese universities and public research エルドアカジノ サイトstitutions.
Invitation to Submit Drug Disエルドアカジノ 紹介コードvery Research Proposals